Butylphthalide for Long-term Efficacy in Minor Stroke Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1200 participants.

Also called NCT07230587

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07230587
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07230587. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-01 (anticipated); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Butylphthalide for Long-term Efficacy in Minor Stroke Study
Acronym
BLESS
Condition
Minor Stroke
Intervention (Drug)
Butylphthalide
Intervention (Drug)
Placebo
Lead sponsor
Peking Union Medical College Hospital (class: other)

Record details

Record id
cardio:ct-nct07230587
Content hash
7dd8c95dd38cdf9849fbc363fc2c4159d24119be0c29ce03db8dd34818fd5dfa